Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP
In this article, the full description of a heart failure with reduced ejection fraction (HF_REF) cohort of 192 patients is provided. Tables with the baseline demographic, prior history, ECG parameters, echocardiographic parameters, laboratory values and pharmacological treatment of these patients ar...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2016-12-01
|
| Series: | Data in Brief |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352340916306473 |
| _version_ | 1819147024081092608 |
|---|---|
| author | M. Batlle B. Campos M. Farrero M. Cardona B. González M.A. Castel J. Ortiz E. Roig M.J. Pulgarín J. Ramírez J.L. Bedini M. Sabaté P. García de Frutos F. Pérez-Villa |
| author_facet | M. Batlle B. Campos M. Farrero M. Cardona B. González M.A. Castel J. Ortiz E. Roig M.J. Pulgarín J. Ramírez J.L. Bedini M. Sabaté P. García de Frutos F. Pérez-Villa |
| author_sort | M. Batlle |
| collection | DOAJ |
| description | In this article, the full description of a heart failure with reduced ejection fraction (HF_REF) cohort of 192 patients is provided. Tables with the baseline demographic, prior history, ECG parameters, echocardiographic parameters, laboratory values and pharmacological treatment of these patients are included. Also, the quartile values of the analyzed circulating biomarkers: high sensitivity Troponin T (hs-TnT), galectin-3 (Gal-3), C-terminal propeptide of type I procollagen (CICP), soluble AXL (sAXL) and Brain Natriuretic Peptide (BNP) are given. The main demographic and clinical features of the patients’ subgroups that have hs-TnT, Gal-3, CICP or BNP above the third quartile are described. Tables with Pearson correlation analysis of the HF_REF patients’ biomarker levels are included. And Pearson correlation analysis of the HF_REF patients’ hs-TnT, Gal-3, CICP levels with patients’ biochemical parameters, blood count and inflammation parameters are also described. These data are related to the research articles (AXL receptor tyrosine kinase is increased in patients with heart failure (M. Batlle, P. Recarte-Pelz, E. Roig, M.A. Castel, M. Cardona, M. Farrero, et al., 2014) [1] and Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in Heart Failure patients with reduced ejection fraction: comparison with soluble AXL and BNP (M. Batlle, B. Campos, M. Farrero, M. Cardona, B. González, M.A. Castel, et al., 2016) [2]. |
| first_indexed | 2024-12-22T13:23:14Z |
| format | Article |
| id | doaj.art-525603c28bd14f03bfd1d75cf277fb04 |
| institution | Directory Open Access Journal |
| issn | 2352-3409 |
| language | English |
| last_indexed | 2024-12-22T13:23:14Z |
| publishDate | 2016-12-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Data in Brief |
| spelling | doaj.art-525603c28bd14f03bfd1d75cf277fb042022-12-21T18:24:24ZengElsevierData in Brief2352-34092016-12-019C87688210.1016/j.dib.2016.10.020Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNPM. Batlle0B. Campos1M. Farrero2M. Cardona3B. González4M.A. Castel5J. Ortiz6E. Roig7M.J. Pulgarín8J. Ramírez9J.L. Bedini10M. Sabaté11P. García de Frutos12F. Pérez-Villa13Institute of Biomedical Research August Pi i Sunyer (IDIBAPS) and the Cardiovascular Clinic Institute, Hospital Clínic de Barcelona, SpainDepartment of Public Health, Universitat de Barcelona, SpainHeart Failure and Transplant Unit, Cardiovascular Clinic Institute, Hospital Clínic de Barcelona and researcher at Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainHeart Failure and Transplant Unit, Cardiovascular Clinic Institute, Hospital Clínic de Barcelona and researcher at Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainCore Laboratory, Hospital Clínic de Barcelona, SpainHeart Failure and Transplant Unit, Cardiovascular Clinic Institute, Hospital Clínic de Barcelona and researcher at Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainHeart Failure and Transplant Unit, Cardiovascular Clinic Institute, Hospital Clínic de Barcelona and researcher at Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainHeart Failure Unit at the Cardiology Department, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Biomèdica (IIB Sant Pau), Universitat Autònoma de Barcelona, Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS) and the Cardiovascular Clinic Institute, Hospital Clínic de Barcelona, SpainPathological Anatomy Department, Hospital Clínic de Barcelona, SpainCore Laboratory, Hospital Clínic de Barcelona, SpainInstitute of Biomedical Research August Pi i Sunyer (IDIBAPS) and the Cardiovascular Clinic Institute, Hospital Clínic de Barcelona, SpainDepartment of Cell Death and Proliferation at Institut d´Investigacions Biomèdiques de Barcelona (IIBB-CSIC) and IDIBAPS, Barcelona, SpainHeart Failure and Transplant Unit, Cardiovascular Clinic Institute, Hospital Clínic de Barcelona and researcher at Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, SpainIn this article, the full description of a heart failure with reduced ejection fraction (HF_REF) cohort of 192 patients is provided. Tables with the baseline demographic, prior history, ECG parameters, echocardiographic parameters, laboratory values and pharmacological treatment of these patients are included. Also, the quartile values of the analyzed circulating biomarkers: high sensitivity Troponin T (hs-TnT), galectin-3 (Gal-3), C-terminal propeptide of type I procollagen (CICP), soluble AXL (sAXL) and Brain Natriuretic Peptide (BNP) are given. The main demographic and clinical features of the patients’ subgroups that have hs-TnT, Gal-3, CICP or BNP above the third quartile are described. Tables with Pearson correlation analysis of the HF_REF patients’ biomarker levels are included. And Pearson correlation analysis of the HF_REF patients’ hs-TnT, Gal-3, CICP levels with patients’ biochemical parameters, blood count and inflammation parameters are also described. These data are related to the research articles (AXL receptor tyrosine kinase is increased in patients with heart failure (M. Batlle, P. Recarte-Pelz, E. Roig, M.A. Castel, M. Cardona, M. Farrero, et al., 2014) [1] and Use of serum levels of high sensitivity troponin T, galectin-3 and C-terminal propeptide of type I procollagen at long term follow-up in Heart Failure patients with reduced ejection fraction: comparison with soluble AXL and BNP (M. Batlle, B. Campos, M. Farrero, M. Cardona, B. González, M.A. Castel, et al., 2016) [2].http://www.sciencedirect.com/science/article/pii/S2352340916306473Heart failureHigh sensitivity troponin TGalectin-3C-terminal propeptide of type I procollagenAXL receptor tyrosine kinaseBrain Natriuretic Peptide |
| spellingShingle | M. Batlle B. Campos M. Farrero M. Cardona B. González M.A. Castel J. Ortiz E. Roig M.J. Pulgarín J. Ramírez J.L. Bedini M. Sabaté P. García de Frutos F. Pérez-Villa Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP Data in Brief Heart failure High sensitivity troponin T Galectin-3 C-terminal propeptide of type I procollagen AXL receptor tyrosine kinase Brain Natriuretic Peptide |
| title | Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP |
| title_full | Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP |
| title_fullStr | Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP |
| title_full_unstemmed | Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP |
| title_short | Data on clinical characteristics of a heart failure patients’ cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers; high sensitivity troponin T, galectin-3, C-terminal propeptide of type I procollagen, soluble AXL and BNP |
| title_sort | data on clinical characteristics of a heart failure patients cohort with reduced ejection fraction and analysis of the circulating values of five different heart failure biomarkers high sensitivity troponin t galectin 3 c terminal propeptide of type i procollagen soluble axl and bnp |
| topic | Heart failure High sensitivity troponin T Galectin-3 C-terminal propeptide of type I procollagen AXL receptor tyrosine kinase Brain Natriuretic Peptide |
| url | http://www.sciencedirect.com/science/article/pii/S2352340916306473 |
| work_keys_str_mv | AT mbatlle dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT bcampos dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT mfarrero dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT mcardona dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT bgonzalez dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT macastel dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT jortiz dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT eroig dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT mjpulgarin dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT jramirez dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT jlbedini dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT msabate dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT pgarciadefrutos dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp AT fperezvilla dataonclinicalcharacteristicsofaheartfailurepatientscohortwithreducedejectionfractionandanalysisofthecirculatingvaluesoffivedifferentheartfailurebiomarkershighsensitivitytroponintgalectin3cterminalpropeptideoftypeiprocollagensolubleaxlandbnp |